Evidence map›Paper›PMID 30227190›Full record

ReviewJournal of the American Academy of Dermatology2019

Nodal staging of high-risk cutaneous squamous cell carcinoma.

Matthew Fox, Marc Brown, Nicholas Golda, Dori Goldberg, Christopher Miller, Melissa Pugliano-Mauro, Chrysalyne Schmults, Thuzar Shin, Thomas Stasko, Yaohui G Xu and 3 more

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Journal of the American Academy of Dermatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05956795 (Surveillance of Regional Nodal Basins in Patients With Primary High Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck), which is not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05956795 terminatednot on this mapstarted 2024, after this paper: background citation

Surveillance of Regional Nodal Basins in Patients With Primary High Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck

TypeobservationalSponsorJohns Hopkins UniversityRan2024 to 2025Enrolled1ConditionsCutaneous Squamous Cell Carcinoma of the Head and NeckArmsUltrasound
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 49 citations in OpenAlex.

  1. Prediction and Prognostication of Peripheral Blood Biomarkers in Head and Neck Cutaneous Squamous Cell Carcinoma.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Using Gene Expression Profiling to Personalize Skin Cancer Management.The Journal of clinical and aesthetic dermatology · 2022
    Review
  16. Review
  17. Article
  18. Update of advanced cutaneous squamous cell carcinoma.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022
    Review
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 1 country.

Matthew FoxDivision of Dermatology at Dell Medical School, University of Texas at Austin, Austin, Texas. Electronic address: mcfox@ascension.org.
Marc BrownDepartment of Dermatology at the University of Rochester, Rochester, New York.
Nicholas GoldaDepartment of Dermatology, University of Missouri, Columbia, Missouri.
Dori GoldbergDivision of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts.
Christopher MillerDepartment of Dermatology, Hospital of the University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Melissa Pugliano-MauroDepartment of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Chrysalyne SchmultsDepartment of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Thuzar ShinDepartment of Dermatology, Hospital of the University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Thomas StaskoDepartment of Dermatology, University of Oklahoma, Norman, Oklahoma.
Yaohui G XuDepartment of Dermatology, University of Wisconsin School of Medicine and Public Health, Milwaukee, Wisconsin.
Kishwer NehalDepartment of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
High Risk Squamous Cell Carcinoma Workgroup
Dermatologic Surgery Section of the Association of Professors of Dermatology
Hospital of the University of Pennsylvania · USBrigham and Women's Hospital · USMemorial Sloan Kettering Cancer Center · USThe University of Texas at Austin · USUniversity of Massachusetts Chan Medical School · USUniversity of Missouri · USUniversity of Oklahoma · USUniversity of Pittsburgh Medical Center · USUniversity of Rochester · USUniversity of Wisconsin–Madison · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundWhile progress has been made in defining the clinical and histopathologic features of high-risk cutaneous squamous cell carcinoma (HRcSCC), optimal staging guidelines remain elusive.

objectiveWe seek to guide clinical practice regarding nodal staging options for patients with HRcSCC via review of evolving definitions of HRcSCC, nodal staging options, and how nodal staging may impact treatment and affect outcomes.

methodsThis was a retrospective review of the published peer-reviewed literature regarding risk stratification, nodal staging, and treatment and outcomes for patients with HRcSCC via PubMed.

resultsFor patients without clinical lymphadenopathy, based on literature from head and neck SCC, preoperative nodal staging with ultrasonography may be more useful than computed tomography or magnetic resonance imaging. Early nodal disease is usually curable, and therefore obtaining a sentinel lymph node biopsy specimen may be considered in those with negative imaging while we await studies of nodal staging outcomes. LIMITATIONS: More data are needed to validate the relationships between primary tumor stage and sentinel lymph node biopsy status and to determine if early detection of nodal disease impacts survival for patients with HRcSCC.

conclusionIt is reasonable to consider nodal staging for patients with HRcSCC (Brigham and Women's Hospital stage T2b and T3) in the absence of clinically palpable lymphadenopathy via radiographic imaging and, if negative, sentinel lymph node biopsy.

Indexed as

Carcinoma, Squamous CellHumansImage-Guided BiopsyLymphatic MetastasisLymph NodesMagnetic Resonance ImagingNeoplasm StagingPositron Emission Tomography Computed TomographyRisk FactorsSentinel Lymph Node BiopsySkin NeoplasmsUltrasonographynodal stagingsentinel lymph node biopsysquamous cell carcinoma

Identifiers

PMID30227190
PMCPMC8081061
OpenAlexW2889754092

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.